𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Interferon-α and ribavirin treatment in patients with hepatitis C virus–related systemic vasculitis

✍ Scribed by Patrice Cacoub; Olivier Lidove; Thierry Maisonobe; Pierre Duhaut; Vincent Thibault; Pascale Ghillani; Robert P. Myers; Jean Marc Leger; Jérôme Servan; Jean-Charles Piette

Publisher
John Wiley and Sons
Year
2002
Tongue
English
Weight
91 KB
Volume
46
Category
Article
ISSN
0004-3591

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effectiveness of hepatitis C treatment w
Effectiveness of hepatitis C treatment with pegylated interferon and ribavirin in urban minority patients
✍ Paul Feuerstadt; Ari L. Bunim; Heriberto Garcia; Jordan J. Karlitz; Hatef Massou 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 211 KB 👁 1 views

Randomized controlled trials of hepatitis C virus (HCV) therapy with pegylated interferon and ribavirin have demonstrated sustained viral response rates (SVRs) of 54%-63% (efficacy). Treatment results in clinical practice (effectiveness) may not be equivalent. The goal of this study was to assess th

Sustained virological response to interf
Sustained virological response to interferon plus ribavirin reduces liver-related complications and mortality in patients coinfected with human immunodeficiency virus and hepatitis C virus
✍ Juan Berenguer; Julio Álvarez-Pellicer; Pilar Miralles Martín; José López-Aldegu 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 208 KB 👁 1 views

Human immunodeficiency virus (HIV) infection modifies the natural history of chronic hepatitis C, thus promoting more rapid progression to cirrhosis and end-stage liver disease. The objective of our study was to determine whether hepatitis C virus (HCV) clearance is associated with improved clinical